References
- Morand EF, Leech M. Macrophage migration inhibitory factor in rheumatoid arthritis. Front Biosci 2005;10:12–22.
- Wijbrandts CA, van Leuven SI, Boom HD, Gerlag DM, Stroes EG, Kastelein JJ, . Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis. Ann Rheum Dis 2009;68:1316–21.
- Lehmann LE, Weber SU, Fuchs D, Klaschik S, Schewe JC, Book M, . Intracellular detection of macrophage migration inhibitory factor in peripheral blood leukocytes. Free Radic Biol Med 2005;38:1170–9.
- Vigna-Perez M, Hernandez-Castro B, Paredes-Saharopulos O, Portales-Perez D, Baranda L, Abud-Mendoza C, . Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther 2006;8:R83.
- Wu J, Cunha FQ, Liew FY, Weiser WY. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 1993;151:4325–32.
- Glennie MJ, French RR, Cragg MS, Taylor RP. Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol Immunol 2007;44:3823–37.
- Riedemann NC, Guo RF, Gao H, Sun L, Hoesel M, Hollmann TJ, . Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils. J Immunol 2004;173:1355–9.
- Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, . MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68–71.